Cycling protocols for GHK-Cu typically involve 8-12 week treatment periods followed by 2-4 week breaks
Some users experience no adverse effects whatsoever while others encounter noticeable injection site reactions that require management strategies
Similarly, BPC-157, derived from a naturally occurring peptide found in gastric juices, has demonstrated an astounding 94% success rate in healing various injuries and ailments, according to recent clinical trials
The milligram figure is route-specific, not a stronger dose than the injection
Potential considerations include: Theoretical concern about promoting angiogenesis in existing tumors (not demonstrated but mechanistically plausible) Possible interactions with dopaminergic medications Limited human safety data due to absence of completed clinical trials GHK-Cu Side Effects# GHK-Cu has an established safety profile, particularly for topical use: Topical formulations are generally well-tolerated with low irritation potential Allergic reactions are rare but possible, particularly in individuals with copper sensitivity Injection site reactions (redness, swelling) can occur with subcutaneous administration No significant systemic side effects reported at standard research doses The extensive commercial use of GHK-Cu in cosmetic products provides a broader real-world safety dataset compared to BPC-157